Business
Brain Scientific To Enter the U.S. Pediatric Market with NeuroCap™ for Children
Brain Scientific To Enter the U.S. Pediatric Market with NeuroCap™ for Children.
About this update from Brain Scientific, Inc.
[{"type":"text","content":"\n NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, has announced its next generation disposable EEG cap, NeuroCap™, will now be available to the pediatric market across the U.S. The product launch allows Brain Scientific to bring faster, more efficient, and sanitary testing procedures to pediatric professionals in the United States. The child-size NeuroCap headset will assist clinicians in overcoming the common obstacles when conducting an electroencephalogram (EEG), including measuring and marking the patient’s head, and conducting required sanitation protocols afterwards. The NeuroCap for children is designed to address the need for comfort, speed, and reliability within the pediatric population. The disposable NeuroCap is a pre-gelled hospital-grade EEG headset that can be applied easily and quickly by any member of a clinical staff. Each headset features 19 active EEG channels and 22 electrodes located in accordance with 10-20 international system. The comfortable design and prompt test results make the NeuroCap an ideal option for pediatric patients in emergency rooms, intensive care units, clinics, and other treatment centers that administer EEG’s on children. The need for EEG testing among children stems from various underlying symptoms and conditions, including seizures, sleep troubles, brain infections, and neurological disorders. Brain Scientific is working to help better equip healthcare facilities nationwide with its easy-to-use solutions for children ranging from 2 to 18 years old, while providing convenience and comfort. The expansion into the pediatric market will also work to make a positive impact on pediatric epilepsy patients, as epilepsy has become one of the most common neurological disorders seen in children as noted by the Pediatrics in Review Journal. Additionally, another common use for children’s EEG testing extends to those experiencing symptoms of ADHD. Children diagnosed with ADHD has increased 42% in the U.S. over the past decade, according to Child and Adolescent Psychiatry. EEG testing is one of the key tools in the diagnosis process to identify disorders and to begin to proactively seek treatment options. The Company expects that the pediatric NeuroCap will provide ...